A pilot study of MUC-1/CEA/TRICOM poxviral-based vaccine in patients with metastatic breast and ovarian cancer.


Abstract

Some patients who had limited tumor burden with minimal prior chemotherapy seemed to benefit from the vaccine.

Further studies to confirm these results are warranted.


Full Text

  • DOI - Clinical cancer research : an official journal of the American Association for Cancer Research (DOI)
  • HighWire Press - full-text online

Subjects


Similar articles

Authors


Publication date

2011-11-17


Journal

Clinical cancer research
Clin Cancer Res (1078-0432)

Journal topics


Language

Eng.


Copyright

Clinical cancer research : an official journal of the American Association for Cancer Research

Medical Oncology Branch and Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.


Release reference

Clin Cancer Res. 2011 Nov;17(22):7164-73



Related books


Español | English

© Galenicom 1999-2013